Home | Published Research | Infusion reactions after receiving the broadly neutralizing antibody VRC01 or placebo to reduce HIV-1 acquisition: Results from the phase 2b antibody-mediated prevention randomized trials

July 15, 2022

Infusion reactions after receiving the broadly neutralizing antibody VRC01 or placebo to reduce HIV-1 acquisition: Results from the phase 2b antibody-mediated prevention randomized trials

Written By

Takuva S, Karuna ST, Juraska M, Rudnicki E, Edupuganti S, Anderson M, et al.